Establish a Real World Evidence Strategy throughout The Product Lifecycle to Articulate Product Value and Encourage Cross-Stakeholder Partnerships with Payers, Providers And Regulatory Bodies
As value-based healthcare continues to transform and changes to FDA Regulations provide pathways to accelerated drug approvals, there is opportunity to leverage real-world data and evidence to establish cross-stakeholder partnerships, improve health outcomes and differentiate a product and brand in the market. The Real-World Data and Evidence Track will showcase successful strategies for optimizing real world data across the product lifecycle, highlight application of use cases, methodologies to assess data, analytical tools, and strategies for implementing end-to-end evidence management.
- Utilize real-world evidence to demonstrate both clinical and cost-effectiveness of your product to payers and providers
- Explore payer, health system and regulatory perspectives to create cross-stakeholder partnerships and better understand acceptance criteria
- Leverage real-world evidence to optimize clinical development and accelerate drug discovery
- Discover digital applications to optimize real- world evidence collection
2019 Featured Speakers:
Vice President, US Medical Affairs, Customer Engagement, Value, Evidence and Outcomes
Vice President, Head of Medical Analytics and Insights, Research, Development and Medical, Upjohn Division
New for 2019:
This summit is a part of the Value-Based Health Care Congress, a five-track event focused on the move from volume to value. This one of a kind meeting brings together stakeholders from all walks of health care - including pharma, biotech, hospitals, health systems, and payer organizations - to break down silos, coordinate efforts, and bend the cost curve.
This meeting is a chance to learn and develop cross-stakeholders partnerships with senior leaders from Payer and Provider organizations. Your pass will include access to the entire Value-Based Health Care Congress.